| HOME >> BIOLOGY >> TECHNOLOGY |
Three months ended June 30, Six months ended June 30
2007 2008 2007 2008
US$ US$ US$ US$
(unaudited) (unaudited) (unaudited) (unaudited)
(In thousands, except (In thousands, except
share and per share data) share and per share data)
Net revenues 73,032 145,667 127,476 233,095
Non-GAAP net income
(note 3) 22,752 35,205 40,749 63,031
Non-GAAP net margin 31.2% 24.2% 32.0% 27.0%
Expense/Amortization
of acquired
intangible assets (613) (9,833) (1,220) (10,490)
Deferred tax impact
related to acquired
intangible assets 92 1,035 183 1,153
Effect of change in
tax rate on
deferred tax -- -- -- --
Share-based
compensation (1,867) (2,350) (3,577) (4,585)
GAAP net income 20,363 24,057 36,135 49,109
GAAP net margin 27.9% 16.5% 28.3% 21.1%
Non-GAAP income per
share - basic 0.21 0.33 0.38 0.59
Non-GAAP income per
share - diluted 0.20 0.31 0.36 0.56
GAAP income per share
- basic 0.19 0.22 0.34 0.46
GAAP income per share
- diluted 0.18 0.21 0.32 0.43
Shares used in
computation of:
Basic earnings per
share 106,163,849 107,263,477 105,962,395 107,113,068
Diluted earn
'/>"/>
| SOURCE Mindray Medical International Limited Copyright©2008 PR Newswire. All rights reserved |